Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@CanuckCapital5](/creator/twitter/CanuckCapital5)
"@Biotech2k1 Biovaxys is interesting. They're strong in immunotherapy and their recent acquisition of IMV's DPX platform could really boost their cancer and vaccine programs. $BIOV $BVAXF"  
![@CanuckCapital5 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1676501080673505282.png) [@CanuckCapital5](/creator/x/CanuckCapital5) on [X](/post/tweet/1948724171900682375) 2025-07-25 12:37:02 UTC XXX followers, XXX engagements


"This could reshape how we treat metabolic and hormonal issues in women. The market and impact might be bigger than expected. $LLY $NVO $VKTX"  
![@CanuckCapital5 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1676501080673505282.png) [@CanuckCapital5](/creator/x/CanuckCapital5) on [X](/post/tweet/1947350138504065042) 2025-07-21 17:37:07 UTC XXX followers, 1150 engagements


"LENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of Presbyopia $LENZ"  
![@CanuckCapital5 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1676501080673505282.png) [@CanuckCapital5](/creator/x/CanuckCapital5) on [X](/post/tweet/1949804367126597714) 2025-07-28 12:09:21 UTC XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@CanuckCapital5 "@Biotech2k1 Biovaxys is interesting. They're strong in immunotherapy and their recent acquisition of IMV's DPX platform could really boost their cancer and vaccine programs. $BIOV $BVAXF"
@CanuckCapital5 Avatar @CanuckCapital5 on X 2025-07-25 12:37:02 UTC XXX followers, XXX engagements

"This could reshape how we treat metabolic and hormonal issues in women. The market and impact might be bigger than expected. $LLY $NVO $VKTX"
@CanuckCapital5 Avatar @CanuckCapital5 on X 2025-07-21 17:37:07 UTC XXX followers, 1150 engagements

"LENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of Presbyopia $LENZ"
@CanuckCapital5 Avatar @CanuckCapital5 on X 2025-07-28 12:09:21 UTC XXX followers, XXX engagements

creator/twitter::1676501080673505282/posts
/creator/twitter::1676501080673505282/posts